Haemonetics
317 hedge funds and large institutions have $4.62B invested in Haemonetics in 2024 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 113 increasing their positions, 107 reducing their positions, and 33 closing their positions.
872% more call options, than puts
Call options by funds: $37.2M | Put options by funds: $3.83M
64% more first-time investments, than exits
New positions opened: 54 | Existing positions closed: 33
8.76% more ownership
Funds ownership: 100.79% → 109.55% (+8.8%)
6% more funds holding
Funds holding: 298 → 317 (+19)
6% more capital invested
Capital invested by funds: $4.37B → $4.62B (+$249M)
6% more repeat investments, than reductions
Existing positions increased: 113 | Existing positions reduced: 107
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Thrivent Financial for Lutherans
Minneapolis,
Minnesota
|
+$73.6M |
| 2 |
Goldman Sachs
New York
|
+$40.1M |
| 3 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
+$37.4M |
| 4 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$36.8M |
| 5 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$33.9M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$38.1M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$22.6M |
| 3 |
Millennium Management
New York
|
-$19.6M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$18.9M |
| 5 |
AIG
American International Group
New York
|
-$7.81M |
HAE Hedge Fund Activity: Q2 2024 in Review
317 of the 6,924 institutional investors tracked by Wall St. Rank reported a position in Haemonetics (HAE) for Q2 2024, worth a combined $4.62B — up 5.7% from $4.37B a quarter earlier.
Buyers outnumbered sellers: 54 funds opened new HAE positions and 33 closed out — a net gain of 21 holders — while 113 added to existing stakes and 107 trimmed.
The largest buyer was Thrivent Financial for Lutherans, adding an estimated $73.6M. The largest seller was Wellington Management Group, cutting an estimated $38.1M.
- 317 institutional investors held Haemonetics (HAE) as of Q2 2024, up from 298 in Q1 2024.
- Funds reported $4.62B of Haemonetics stock for Q2 2024, up 5.7% quarter-over-quarter.
- 54 funds opened new Haemonetics positions in Q2 2024 and 33 closed out, a net change of +21 holders.
- The largest Haemonetics buyer in Q2 2024 was Thrivent Financial for Lutherans, an estimated $73.6M added.
- The largest Haemonetics seller in Q2 2024 was Wellington Management Group, an estimated $38.1M sold.
Based on aggregated 13F filings for Q2 2024.